Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Clinical Proteomics, CPTAC, Cancer Biomarkers

Steven Carr

PhD

🏢Broad Institute of MIT and Harvard🌐USA

Senior Director, Proteomics

82
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Steven Carr is a leading figure in clinical proteomics and was a key architect of the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC), which has generated comprehensive proteomic and phosphoproteomic datasets across multiple cancer types. His laboratory develops mass spectrometry methods for precise quantification of proteins and phosphorylation events in clinical samples. He has contributed to linking genomic alterations to protein-level consequences and identifying actionable therapeutic targets through integrated proteogenomics. His work represents a major advance in translational cancer proteomics.

Share:

🧪Research Fields 研究领域

CPTAC
clinical proteomics
phosphoproteomics
cancer biomarker discovery
targeted proteomics

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Steven Carr 的研究动态

Follow Steven Carr's research updates

留下邮箱,当我们发布与 Steven Carr(Broad Institute of MIT and Harvard)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment